MARILYNN SHAW: Open Payments
NPI 1114400967 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 28 payments from 7 companies in 2025. Trend: 2023 $2,271 · 2024 $1,148 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 13 | $150 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $70 |
| Alnylam Pharmaceuticals Inc. | 2 | $47 |
| CVRx, Inc. | 2 | $25 |
| AltaThera Pharmaceuticals LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: UPTRAVI, LifeVest, LEQVIO, AMVUTTRA, Barostim Neo System, Sotalol Hydrochloride, JARDIANCE.
Industry payments across CA — which companies pay providers there.
